The VIP Peptide Math: One Trial Failed, Two Small Ones Didn’t, and the Buying Decision Isn’t Close
Here’s the number I keep coming back to: 38 versus 36. That’s the ninety-day mortality rate, in percent, for…
End of content
End of content
Here’s the number I keep coming back to: 38 versus 36. That’s the ninety-day mortality rate, in percent, for…
End of content
End of content